Showing items 1–100
Low eructation composition and methods for treating and/or preventing cardiovascular…
Grant US-11712429-B2
United States of America
Low eructation composition and methods for treating and/or preventing cardiovascular…
Grant US-11712428-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-11690820-B2
United States of America
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a…
Grant US-11547710-B2
United States of America
Compositions and methods for lowering triglycerides
Grant US-11464757-B2
United States of America
Methods of reducing or preventing oxidation of small dense LDL or membrane…
Grant US-11446269-B2
United States of America
Compositions and methods for lowering triglycerides
Grant US-11439618-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-11400069-B2
United States of America
Methods of reducing the risk of cardiovascular events in a subject
Grant US-11369582-B2
United States of America
Methods of reducing the risk of cardiovascular events in a subject
Grant US-11298333-B1
United States of America
Compositions and methods for lowering triglycerides without raising LDL-C levels in a…
Grant US-11285127-B2
United States of America
Compositions and methods for lowering triglycerides without raising LDL-C levels in a…
Grant US-11229618-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-11213504-B2
United States of America
Methods of reducing apolipoprotein C-III
Grant US-11185525-B2
United States of America
Compositions and methods for lowering triglycerides without raising LDL-C levels in a…
Grant US-11179362-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-11154526-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-11147787-B2
United States of America
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary…
Grant US-11141399-B2
United States of America
Methods of reducing the risk of cardiovascular events in a subject
Grant US-11116742-B2
United States of America
Methods of reducing the risk of cardiovascular events in a subject
Grant US-11116743-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-11103477-B2
United States of America
Compositions and methods for lowering triglycerides in a subject on concomitant statin…
Grant US-11058661-B2
United States of America
Methods of reducing RLP-C
Grant US-11052063-B2
United States of America
Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of…
Grant US-11033523-B2
United States of America
Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a…
Grant US-11007173-B2
United States of America
Methods of reducing the risk of cardiovascular events in a subject
Grant US-11000499-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-10987331-B2
United States of America
Methods of reducing apolipoprotein c-III
Grant US-10973797-B2
United States of America
Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP…
Grant US-10973796-B2
United States of America
Compositions and methods for lowering triglycerides in a subject having reduced kidney…
Grant US-10966951-B2
United States of America
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
Grant US-10966968-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-10940131-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject at risk for…
Grant US-10894028-B2
United States of America
Pharmaceutical compositions comprising omega-3 fatty acids
Grant US-10888537-B2
United States of America
Methods of treating or preventing prostate cancer
Grant US-10888539-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-10881632-B2
United States of America
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
Grant US-10851374-B2
United States of America
Compositions and methods for lowering triglycerides
Grant US-10842768-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-10842766-B2
United States of America
Methods of reducing or preventing oxidation of small dense ldl or membrane…
Grant US-10842765-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject at risk for…
Grant US-10792270-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-10792267-B2
United States of America
Methods of reducing the risk of cardiovascular events in a subject
Grant US-10786478-B2
United States of America
Compositions and methods for lowering triglycerides without raising LDL-C levels in a…
Grant US-10722485-B2
United States of America
Methods of reducing apolipoprotein C-III
Grant US-10675263-B2
United States of America
Methods of reducing the risk of cardiovascular events in a subject
Grant US-10668042-B2
United States of America
Methods of treating hypertriglyceridemia
Grant US-10632094-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-10624870-B2
United States of America
Methods of reducing apolipoprotein C-III
Grant US-10610508-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject at risk for…
Grant US-10576054-B1
United States of America
Methods of reducing the risk of a cardiovascular event in a subject at risk for…
Grant US-10568861-B1
United States of America
Methods of reducing RLP-C
Grant US-10561631-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject at risk for…
Grant US-10555924-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject at risk for…
Grant US-10555925-B1
United States of America
Methods of treating hypertriglyceridemia
Grant US-10537544-B2
United States of America
Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a…
Grant US-10493058-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-10449172-B2
United States of America
Methods of reducing or preventing oxidation of small dense LDL or membrane…
Grant US-10406130-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject at risk for…
Grant US-10383840-B2
United States of America
Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and…
Grant US-10314803-B2
United States of America
Compositions and methods for lowering triglycerides without raising LDL-C levels in a…
Grant US-10292959-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-10278938-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-10278935-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-10278939-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-10278936-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-10278937-B2
United States of America
Methods of reducing triglycerides and LDL-C
Grant US-10265287-B2
United States of America
Methods of reducing apolipoprotein C-III
Grant US-10265290-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-10220013-B2
United States of America
Compositions and methods for treating or preventing obesity in a subject in need thereof
Grant US-10206898-B2
United States of America
Methods of reducing or preventing oxidation of small dense LDL or membrane…
Grant US-10172818-B2
United States of America
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
Grant US-10167467-B2
United States of America
Methods of reducing apolipoprotein C-III
Grant US-10166209-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-10016386-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-10010517-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9918954-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9918955-B2
United States of America
Methods of treating mixed dyslipidemia
Grant US-9855237-B2
United States of America
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use…
Grant US-9855240-B2
United States of America
Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP…
Grant US-9827219-B2
United States of America
Compositions comprising EPA and obeticholic acid and methods of use thereof
Grant US-9814733-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9693986-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9693985-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9693984-B2
United States of America
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use…
Grant US-9662307-B2
United States of America
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
Grant US-9624492-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9623001-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9610272-B2
United States of America
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Grant US-9603826-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-9585856-B2
United States of America
Compositions and methods for lowering triglycerides without raising LDL-C levels in a…
Grant US-9585859-B2
United States of America
Methods of reducing apolipoprotein C-III
Grant US-9452151-B2
United States of America
Compositions and methods for treating or preventing obesity in a subject in need thereof
Grant US-9283201-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-9138415-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-9072715-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-9060982-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-9060983-B2
United States of America
Pharmaceutical compositions comprising fatty acids
Grant US-9056088-B2
United States of America
Stable pharmaceutical composition and methods of using same
Grant US-8709475-B2
United States of America
Showing items 1–100